State Key Laboratory of Molecular Oncology;
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital;
Chinese Academy of Medical Sciences and Peking Union Medical College;
Beijing 100021;
China;
State Key Laboratory of Medical Genomics;
Shanghai Institute of Hematology;
National Research Center for Translational Medicine(Shanghai);
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine;
Shanghai 200025;
China;
COVID-19; SARS-CoV-2; pathogenesis; evidence-based medicine; control and therapeutic strategies;